US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3309-4 D-1603-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3308-4 D-1602-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3307-4 D-1601-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3305-4 D-1600-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3303-4 D-1599-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3299-4 D-1598-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3302-4 D-1597-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3300-4 D-1596-2020
Class II · Moderate risk Terminated

Cephalexin for Oral Suspension

Reason Sub-Potent Drug: Out of specification test results for potency (below specification).

Teva Pharmaceuticals USA NDC 0093-4177-73 D-1566-2020
Class II · Moderate risk Terminated

Cephalexin for Oral Suspension

Reason CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Teva Pharmaceuticals USA NDC 0093-4177-73 D-0013-2021
Class II · Moderate risk Terminated

Cephalexin for Oral Suspension

Reason CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Teva Pharmaceuticals USA NDC 0093-4175-73 D-0012-2021
Class II · Moderate risk Terminated

Zanilast+ Gel Antiseptic Hand Sanitizer

Reason GMP Deviations: Potential to contain 1-propanol.

Nanomateriales Sa De Cv NDC 69912-006-01 D-1593-2020
Class II · Moderate risk Terminated

Zanilast+ Gel Antiseptic Hand Sanitizer

Reason GMP Deviations: Potential to contain 1-propanol.

Nanomateriales Sa De Cv NDC 69912-008-01 D-1592-2020
Class I · High risk Terminated

Goldenseal Root Powder Organic

Reason Microbial Contamination of Non-Sterile Products: FDA laboratory analysis found product to be contaminated with various microorganisms including Enterobacter cloacae, Cronobacter sakazakii, Cronobacter dublinensis, among others.

Maison Terre, LLC D-1584-2020
Class I · High risk Terminated

Tranexamic Acid Injection

Reason Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

Mylan Institutional LLC NDC 67457-197-00 D-1576-2020
Class I · High risk Terminated

Amiodarone Hydrochloride Injection

Reason Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

Mylan Institutional LLC NDC 67457-153-99 D-1575-2020